C07B 53 - Asymmetric syntheses

Patents for C07B 53 - Asymmetric syntheses (6,231)
12/2004
12/28/2004	US6835851 Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids
12/28/2004	US6835838 Condensation of silicon compounds with aldehydes in the presence of titanium catalysts in solvents, then reducing and hydolyzing to form drugs used for prophylaxis of atherosclerosis or as enzyme inhibitors
12/23/2004	WO2004111065A1 Ligands
12/23/2004	WO2004111063A2 Chiral ligands for application in asymmetric syntheses
12/23/2004	WO2004110977A1 Process for producing optically active 1-alkyl-substituted 2,2,2-trifluoroethylamine
12/23/2004	WO2004085485A8 Crosslinked three-dimensional polymer network, method for preparing same, support material comprising same and uses thereof
12/23/2004	US20040260101 With difluoromethylenedioxybenzene or ethylenedioxybenzene rings; hydrogenation catalysts
12/23/2004	US20040260091 Ligands for asymmetric reactions
12/23/2004	CA2528238A1 Ligands
12/22/2004	EP1489070A1 Process for production of optically active compounds
12/21/2004	US6833461 Process for preparing simvastatin
12/21/2004	US6833442 Complex and method for producing epoxides by using the complex
12/21/2004	CA2134674C Gaba and l-glutamic acid analogs for antiseizure treatment
12/16/2004	US20040254209 oxidation with potassium permanganate to cleave oxazolidinedione ring in methanol solvent, and reacting with potassium t-butoxide in dimethylformamide to deblock; testosterone-5 alpha -reductase inhibitors, for treatment of hyperandrogenic disorders
12/16/2004	US20040254066 Dissolving or dispersion forming emulsion; transition metal catalyst encapsulated within a permeable polymer; catalyst for foirming polyol from olefin
12/15/2004	EP1485496A2 Deracemisation of amines
12/15/2004	EP1485357A1 Process for asymmetric hydrogenation of hexahydroquinoline salts
12/15/2004	EP1485351A2 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
12/15/2004	EP1317427B1 Method for producing chiral compounds
12/15/2004	CN1554650A Process for the preparation of vialoguestamin d analogs
12/15/2004	CN1179939C Method for production of adrenaline
12/15/2004	CN1179938C Process for producing vitamin D analogue
12/09/2004	WO2004106269A1 Method for producing substituted shiral diols and diol-analogous derivatives
12/09/2004	US20040249220 Process for producing optically active 2-alkoxy-1-(trifluoromethyl-substituted phenyl) ethanol derivatives
12/09/2004	US20040249187 Method for producing chiral amino acid derivatives
12/09/2004	US20040249184 aromatic fused phosphepine ligands, e.g., 4-Phenyl-4,5-dihydro-3H-dinaphtho[2,1-c; 1',2'-e]phosphepine and their preparation from 2,2'-dimethylbiphenyls or binaphthyls and aminophosphorus dichlorides or aryl or alkyl phosphorus dichlorides; hydrogenation catalysts with metal compounds
12/09/2004	US20040249174 Synthesis of cannabinoids
12/09/2004	US20040249172 Process for the preparationof prostaglandins and analogues thereof
12/09/2004	US20040249154 Process for the manufacture of organic compounds
12/09/2004	US20040248910 Synthesis of acyclic nucleoside derivatives
12/09/2004	DE10323692A1 Chirale Liganden und deren Übergangsmetallkomplexe Chiral ligands and their transition metal complexes
12/08/2004	EP1483276A1 Ferrocenyl ligands and the use thereof in catalysis
12/08/2004	EP1483273A2 Ligands for asymmetric reactions
12/08/2004	EP1483256A2 Process for making chiral 1,4-disubstituted piperazines
12/08/2004	EP1251120B1 Esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl
12/08/2004	CN1178912C Small molecule inhibitors of rotamase enzyme activity
12/07/2004	US6828271 To form transition metal complexes which are used in such as asymmetric hydrogenation of imines, asymmetric hydride transfer reactions, hydrosilylation, hydroboration, hydrovinylation hydroformylation, allylic alkylation, etc.
12/02/2004	WO2004104014A2 Chiral ligands and their transition metal complexes
12/02/2004	WO2004103990A1 Process for producing optically active n-monoalkyl-3hydroxy-3-arylpropylamine compound and intermediate
12/02/2004	WO2004103560A1 Catalytic composition and process for asymmetric hydrogenation
12/02/2004	US20040242916 Process for preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
12/02/2004	US20040242652 Beta benzyloxyaspartate derivatives with amino group on benzene ring
12/02/2004	CA2526497A1 Catalytic composition and process for asymmetric hydrogenation
12/01/2004	EP1482054A1 Process for preparation of optically active allenes
12/01/2004	EP1482020A1 Pyran derivatives with an exocyclic double bond
12/01/2004	EP1480980A2 Syntheses of quinazolinones
12/01/2004	EP1480975A2 Chemical compounds
12/01/2004	EP1480964A1 Inhibiteurs de l'angiogenese
12/01/2004	EP1480963A1 Method for producing 3-amidinophenylalanine derivatives
12/01/2004	EP1200394A4 Process for preparing acids via alpha-chloroepoxy esters
12/01/2004	CN1550553A Process for the preparation of (1S,4R) or (1R,4S)-1-amino-4-(methylol)-2-cyclopentene and its derivatives or its salts
12/01/2004	CN1550500A Process for the preparation of (1S,4R) or (1R,4S)-4-(2-amino-6-chloro-9-H-purine-9-group)-2-cyclopentenyl-1-methanol or its salts
12/01/2004	CN1550490A Process for the preparation of aminoalcohol and (1S,4Rú®or (1R,4S)-1-amino-4-(methylol)-2-cyclopentene or its salts
12/01/2004	CN1177793C Microbial process for preparing pravastatin
11/2004
11/30/2004	US6825220 3-Substituted oxindole β 3 agonists
11/30/2004	CA2365859C 4-cyano-3-hydroxy butanoyl hydrazines, derivatives and process for the preparation thereof
11/25/2004	US20040236142 Using a lactide; oligomerization
11/25/2004	US20040236141 reacting oxy nitriles with solutions of inorganic acid in an alcohols, to form carbocyclic oxy esters and isomers, used as chemical intermediates for angiotensin converting enzyme inhibitors
11/25/2004	US20040236129 Optically active catalysts
11/25/2004	US20040235928 Process for the preparation of optically active amines or salts thereof
11/25/2004	US20040235864 Jun kinase inhibitors
11/24/2004	EP1159265B1 C-16 unsaturated fp-selective prostaglandins analogs
11/24/2004	CN1549818A Isoxazoline derivatives as P, N ligands
11/24/2004	CN1176902C New esters derived from substituted phenyl-cyclohexyl compounds
11/23/2004	USRE38659 Esters with musky odor and their use in perfumery
11/23/2004	CA2316157C Process for the preparation of vitamin d analogues
11/18/2004	WO2004099226A1 Substituted ferrocenyldiphosphines as ligands for homogeneous hydrogenation catalysts
11/18/2004	US20040230077 Asymmetric sulfimidation of aryl sulfide with azide using optically active ruthenium complex catalyst; selectivity, purity, yield, low cost;
11/18/2004	US20040229846 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
11/17/2004	EP1476439A1 Preparation of n-methyl-3-hydroxy- 3-(2-thienyl)propylamine via novel thiophene derivatives containing carbamate groups as intermediates
11/17/2004	CN1547576A Process for ascorbic acids using alkaline earth silicate catalysts
11/17/2004	CN1176104C Process for preparation of acetyl-guanylphenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/16/2004	US6818423 Process for the preparation of chiral α-hydroxycarboxylic acids
11/11/2004	WO2004096753A1 ASYMMETRIC-SYNTHESIS CATALYST BASED ON CHIRAL BR&dollar;NSTED ACID AND METHOD OF ASYMMETRIC SYNTHESIS WITH THE CATALYST
11/11/2004	WO2004085344A3 Production of oxy-michael adducts
11/11/2004	US20040225109 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridinioalaninamides
11/11/2004	US20040225007 Different physicochemical properties with different X-ray diffraction patterns; antiinflammatory and cytoprotective agent, treat diabetes mellitus and insulin resistance, glucose metabolic disorders of the central nervous system and appetite suppressant
11/10/2004	EP1242361B1 Process of preparing tolterodine and analogues there of as well as intermediates prepared in the process
11/10/2004	CN1174804C Chiral salen catalysts, and process for preparing chiral compounds from racemic epoxides for using them
11/04/2004	US20040220413 Subjecting a specified olefin to an asymmetric aziridination or amination with a specified arylsulfonyl azide compound using using a specified ruthenium (salen) carbonyl complex as a catalyst
11/04/2004	US20040220049 Solid rhodium complex hydrogenation catalyst on catalyst support
11/03/2004	EP1472228A1 Process for the manufacture of hmg-coa reductase inhibitors
11/03/2004	EP1472227A2 Process for the manufacture of organic compounds
11/03/2004	EP1317461B1 4-cyclohexyl-1,3,2-oxazaborolidine chiral accessories
11/03/2004	EP1305278B1 Ruthenium complexes and their use in asymmetric hydrogenation
11/03/2004	EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues
11/03/2004	CN1543454A Method for preparation of (s)-(+)-and(r)-(-)10,11-dihydro-10-hydrodoxy-5h-dibenz/b,f/azephine-5-carboxamide
11/03/2004	CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004	CN1173985C Novel diphenylarsines
11/03/2004	CN1173938C Alpha-substitution of unprotected beta-amino ester compounds
11/03/2004	CN1173928C Process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
11/02/2004	US6812368 Diastereoselective hydrogenation of 1,3-hydroxyketones
10/2004
10/28/2004	WO2004092104A1 Process for producing 2-(l-menthoxy)ethanol compound
10/28/2004	US20040215027 Locates chirality closer to the metal center than known metal phospholane complexes; provides high enantiomeric excesses
10/28/2004	US20040214874 Inhibition of protein-tyrosine kinase cmet to block cancer cell proliferation, oral bioavailibility; 2-(2,6-dichlorophenyl)-4-phenyl-5-(pyrimidin-4yl)-1H-imidazoles
10/27/2004	EP1469851A1 Melanocortin receptor agonists
10/27/2004	CN1539838A Recoverable repeatable use chirality cinchona alkaloid ligand and application
10/26/2004	US6809225 Method for producing 3,3-diarylpropylamines
10/26/2004	US6809223 Process for stereoselective synthesis of prostacyclin derivatives
10/26/2004	US6809214 Shortened synthesis of 3,3-diarylpropylamine derivatives

1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 63